
Darragh Lyons
IT IS hard to understand exactly what is going on inside Malin Corp, the hotchpotch pharmaceutical investment holding company that Kelly Martin set up eight years ago before bailing two years later. What is clear is that Malin is in trouble as the value of its assets has plummeted, with a cash cushion looking like… Read more »
To access The Phoenix Archive, you must pay a fee of €20 for 3 months.



